logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
返回期刊详情
Current Hematologic Malignancy Reports 封面图

Current Hematologic Malignancy Reports

IF3.3
论文数58
被引数1303
期刊论文 58
发表时间
delete
The Evolving Landscape of Reduced-Intensity Conditioning: Balancing Efficacy and Toxicity Across Hematologic Malignancies减低强度预处理方案的演变：在血液恶性肿瘤中平衡疗效与毒性
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-10-29
delete0
deleteOAAI
deletePiyatida Chumnumsiriwath; Stefan O. Ciurea; Piyanuch Kongtim
delete分享
delete收藏
FLT3-Mutated AML: Transplanting with Precision in the Targeted EraFLT3突变型AML：靶向时代的精准移植
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-10-01
delete0
PREAI
deleteJoseph F. Mort; Alex J. Ambinder
delete分享
delete收藏
Molecular Response, Event-Free Survival, and Treatment-Free Remission in Myeloproliferative Neoplasms: Update and Review with Insights from MPN Asia 2026分子应答、无事件生存和治疗后缓解在骨髓增殖性肿瘤中的应用：更新与综述及MPN Asia 2026的见解
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-09-18
delete0
deleteOAAI
deleteGhaith Abu-Zeinah; Gabriela S. Hobbs; Raajit K. Rampal; Sung-Eun Lee; Harinder Gill; Rami Komrokji; Tsewang Tashi; Prithviraj Bose; John Mascarenhas; Abdulraheem Yacoub; Stephen T. Oh; Kazuya Shimoda; Brandi N. Reeves; Minghui Duan; Lennex Hsueh-Lin Yu; Albert Qin; Josef T. Prchal; Kenneth Kaushansky; Ruben A. Mesa
delete分享
delete收藏
Strategies to Overcome Inequities in the Treatment of Patients with Hematologic Malignancies克服血液系统恶性肿瘤患者治疗中不平等的策略
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-09-11
delete0
PREAI
deleteCarlos de la Cruz-de la Cruz; Yessica M. González-Mártinez; Andrés Gómez-De León
delete分享
delete收藏
Real World Data and Its Impact on the Management of Plasma Cell Dyscrasias真实世界数据及其对浆细胞异常增殖性疾病管理的影响
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-29
delete0
PREAI
deleteNaveen Subramanian; Samuel M. Rubinstein
delete分享
delete收藏
Linking Air Pollution and Hematologic Malignancies: From Epidemiology to Molecular Mechanisms将空气污染与血液系统恶性肿瘤联系起来：从流行病学到分子机制
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-11
delete0
deleteOAAI
deleteHamsa Murli; Sadia Alam; Evelyn Mesler; Aditi Shastri
delete分享
delete收藏
Antigen Pressure, Clonal Evolution, and Lineage Plasticity in B-Cell Acute Lymphoblastic Leukemia: Resistance Biology in the Immunotherapy Era抗原压力、克隆进化和谱系可塑性在B细胞急性淋巴细胞白血病中的作用：免疫治疗时代的耐药生物学
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-07
delete0
PREAI
deleteJulio Alvarenga Thiebaud; Tamer Othman; Ibrahim Aldoss
delete分享
delete收藏
Beyond Survival: Measuring Treatment Tolerability with Patient-Reported Outcomes in the Lymphoma Immunotherapy Era超越生存：在淋巴瘤免疫治疗时代，利用患者报告结局评估治疗耐受性
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-07
delete0
PREAI
deleteElisa Hofmeister; Ajay Major
delete分享
delete收藏
Chronic Myelomonocytic Leukemia: History, Pathobiology, Diagnostic Controversies, and Evolving Classification慢性骨髓单核细胞白血病：历史、病理生物学、诊断争议及演变中的分类
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-08-03
delete0
deleteOAAI
deleteSanam Loghavi; Robert P. Hasserjian
delete分享
delete收藏
Breaching the Blood-Brain Barrier: Evolving Strategies for Central Nervous System Disease in Adult Acute Lymphoblastic Leukemia突破血脑屏障：成人急性淋巴细胞白血病中枢神经系统疾病的治疗策略演变
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-07-13
delete0
deleteOAAI
deleteLiesl S. Eibschutz; Samuel Crow; Caroline Tatum; Daniel Reed; Michael Keng
delete分享
delete收藏
Correction: Clonal Signatures of Telomere Biology Disorders更正：克隆特征与端粒生物学障碍
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-07-10
delete0
PREAI
deleteLuca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
delete分享
delete收藏
BRAF Alterations in Chronic Lymphocytic Leukemia: Genomic Landscape, Co-Mutation Patterns, and Clinical Relevance慢性淋巴细胞白血病的BRAF基因突变：基因组景观、共突变模式及其临床相关性
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-05-01
delete0
deleteOAAI
deleteAbdulrahman Al-Abdulmalek; Eric Landry; Mohammed Abdulgayoom; Abdulrahman F. Al-Mashdali; Ayman Abdullah Dalol; Bassam Muthanna; Jean-Pierre Routy; Shehab F. Mohamed
delete分享
delete收藏
Targeting the BCR::ABL1 Kinase: Advances Beyond Imatinib in Chronic Myeloid Leukemia靶向BCR::ABL1激酶：慢性粒细胞白血病中伊马替尼之外的进展
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-25
delete0
PREAI
deleteZuhal Naderi; Teresa Sadras; Susan Branford; Naranie Shanmuganathan; Ilaria S. Pagani
delete分享
delete收藏
Germline DDX41 Variants: Current Understanding and Future Directions生殖系DDX41变异：当前理解与未来方向
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-23
delete0
PREAI
deleteAldo A. Acosta-Medina; Abhishek A. Mangaonkar
delete分享
delete收藏
Clonal Signatures of Telomere Biology Disorders端粒生物学疾病的克隆性特征
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-04-14
delete0
deleteOAAI
deleteLuca Arcuri; Emma M. Groarke; Sharon A. Savage; Fernanda Gutierrez-Rodrigues
delete分享
delete收藏
Molecular Pathogenesis and Targeted Therapies for Myeloproliferative Hypereosinophilic Neoplasms骨髓增殖性高嗜酸性粒细胞肿瘤的分子发病机制与靶向治疗
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-03-07
delete0
deleteOAAI
deleteColette Hanna; Joe Rizkallah; Nicole Charbel; Shereen Sakkal; Fadi G. Haddad
delete分享
delete收藏
The Intricate Dance Between Inflammation and Myeloproliferative Neoplasms: From Origins to Outcomes炎症与骨髓增殖性肿瘤之间错综复杂的关系：从起源到结局
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-03-06
delete0
deleteOAAI
deleteAngela G Fleischman
delete分享
delete收藏
When Targeted Therapy Falls Short: Unraveling Resistance Mechanisms in Chronic Lymphocytic Leukemia当靶向治疗效果不佳时：解析慢性淋巴细胞白血病的耐药机制
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-26
delete0
deleteOAAI
deleteSamon Benrashid; Jennifer A. Woyach
delete分享
delete收藏
Inotuzumab Ozogamicin in Clinical Practice: an Overview of Efficacy, Safety, and Real-World Applications伊诺妥单抗奥扎胞苷在临床实践中的应用：疗效、安全性及真实世界应用的概述
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-24
delete0
deleteOAAI
deleteValerie Tran; Nandan Srinivasa; Caroline Tatum; Daniel Reed; Michael Keng
delete分享
delete收藏
New Approaches for Measurable Residual Disease Assessment in Multiple Myeloma: Integrating NGS, Mass Spectrometry, and Next-Generation Flow Cytometry to Monitor Treatment Response新方法用于多发性骨髓瘤微小残留病灶评估：整合NGS、质谱技术和下一代流式细胞术监测治疗反应
deleteCurrent Hematologic Malignancy Reports
IF3.3
delete2026-02-14
delete0
PREAI
deleteBhavesh Mohan Lal; Shaji K. Kumar
delete分享
delete收藏